About Cambridge Biotechnology

Cambridge Biotechnology Ltd (CBT) is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class "gene to lead" drug discovery capability.

Facts about Cambridge Biotechnology
  • Focus : Manufacturer
  • Industry : Biotechnology

Here you will find Cambridge Biotechnology Ltd.